Yoanna S Pumpalova, Adarsh Ramakrishnan, Michael May, Audrey Pentz, Shauli Minkowitz, Sean Doherty, Elvira Singh, Wenlong Carl Chen, Timothy R Rebbeck, Alfred I Neugut, Maureen Joffe
BACKGROUND: Men of African descent are disproportionately affected by prostate cancer (PCa), and many have metastatic disease at presentation. In South Africa (SA), androgen deprivation therapy (ADT) is the first-line treatment for stage IV PCa. OBJECTIVE: To identify predictors of overall survival (OS) in Black South African men with stage IV PCa treated with ADT. DESIGN, SETTING, AND PARTICIPANTS: Men diagnosed with prostate cancer (3/22/2016-10/30/2020) at Chris Hani Baragwanath Academic Hospital in Soweto, Johannesburg, were recruited for the Men of African Descent with Cancer of the Prostate study...
December 29, 2023: Cancer Medicine